HomeBODDan Jacob Gelvan, Ph.D., Managing Director, Life Sciences, Aurum Ventures MKI
Dan Jacob Gelvan,
Ph.D., Managing Director, Life Sciences, Aurum Ventures MKI
Dan Jacob Gelvan, Ph.D., Managing Director, Life Sciences, Aurum Ventures MKI
Dr. Gelvan is a seasoned life-science executive with over twenty years of experience working with emerging stage life sciences companies. Dr. Gelvan is a Managing Director with Aurum Ventures where he is responsible for life science investment (privately held $100M+ fund). Dr. Gelvan was a senior executive with GammaCan International, Inc. (OTCBB: GCAN), a pharmaceutical company that focused on immunotherapy in oncology and founded and managed Zetiq Technologies, which specializes in cell-based high-throughput screening for novel anti-cancer drugs and cancer diagnosis. Dr. Gelvan founded Zetiq after leaving a senior position at Clal (Israel) Ltd., one of Israel’s largest holding conglomerates. Dr. Gelvan holds a Ph.D. in Business Economics from RUC in Denmark and is an experienced lecturer in corporate finance and entrepreneurship. Dr. Gelvan was a member of Israel’s National Committee for Biotechnology.